Position in CYTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,049,944
-$28,532,198 QoQ
Shares Held
91,791
-77.8% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Sep 30, 2023CallValue
$0
CallShares
0
PutValue
$14,730,000
PutShares
500,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sofinnova Investments, Inc. holds $1,182,454,857 across 43 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VERA |
Vera Therapeutics, Inc.
|
2,793,987 | $119,889,982 | |
| 2 | GMAB |
Genmab A/S
|
4,045,215 | $111,122,056 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
365,341 | $88,036,220 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
1,904,408 | $79,356,681 | |
| 5 | SPTX |
Seaport Therapeutics, Inc.
|
3,564,871 | $77,428,998 | |
| 6 | AVBP |
ArriVent BioPharma, Inc.
|
1,696,752 | $58,945,164 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,717,505 | $57,347,491 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
408,027 | $45,303,237 |
All Filings in CYTK
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,049,944 | 91,791 | Shares | Sole | 2026-05-15 | |
| 2023-12-31 | $34,582,142 | 414,207 | Shares | Sole | 2024-08-15 | |
| 2023-09-30 | $14,730,000 | 500,000 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $31,232,431 | 1,060,164 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $27,506,097 | 843,228 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,450,081 | 353,796 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,582,000 | 100,000 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $23,319,172 | 508,930 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,538,980 | 320,722 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $12,603,446 | 320,780 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,316,968 | 62,944 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,165,802 | 464,366 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $15,247,827 | 426,632 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,525,382 | 481,323 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,064,887 | 389,720 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $10,564,427 | 508,394 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,562,257 | 349,296 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,776,313 | 160,217 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||